Login

Biju Kulathakal, CEO and Co-Founder of Halo Investing, displays a sign at the office entrance stating "Impact Over Everything" to emphasize the company's core value. 00:10:00

Share On Facebook Share On Twitter

David Parker · CEO at Halo Security

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
China's Energy Transition and Global Metal Demand Amidst Geopolitical Shifts
00:10:00
Investing Basics: Why You Should Start Now with Laurel Hardy | Laurel Hardy, CEO, Bespoke Wealth Management.
00:00:00
Amy C. Degnim, M.D. Surgical Oncologist, Mayo Clinic / Breast cancer treatment planning - Mayo Clinic
00:10:00
upport cybersecurity entrepreneurs with the capital|Alex Doll, Managing General Partner,Ten Eleven Ventures
00:10:00
Mayfield is a global venture capital firm with a 50+ year history of investing in relationships with entrepreneurs from inception to iconic|Navin Chaddha,Managing Partner, Mayfield Fund
00:10:00
The firm investing in technology and healthcare for betterment|Liza Landsman,General Partner,New Enterprise Associates (NEA)
00:10:00
"Unlocking Value: Why Boardwalk REIT Presents a Compelling Investment Opportunity"|CFO,Boardwalk Real Estate Investment Trust
00:10:00
Adani Wilmar Reports Robust Q2 Growth with EBDITA Surging 4x and Food & FMCG Boost | Angshu Mallick, CEO , Adani Wilmar Ltd.
00:10:00
Simplify Your Finances with Expert CFP Guidance
00:10:00
Polaris CEO and Chairman Scott Wine discusses the company's most recent quarter on CNBC's "Squawk Alley."|Jae-Ho Kim is Director & Head-Management Support at Polaris Office Corp.
00:10:00
Millennium Investment's Focus on Activated Carbon for Energy Storage
00:10:00
Pelion Venture Partners helps entrepreneurs and invests in early-stage B2B|Jeff Kearl,Partner,Pelion Venture Partners

© 2017 - Neuhu+